Ligtenberg G - Search Results

1

Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis.

Zilch O, Vos PF, Oey PL, Cramer MJ, Ligtenberg G, Koomans HA, Blankestijn PJ. Zilch O, et al. Among authors: ligtenberg g. J Hypertens. 2007 Jun;25(6):1285-9. doi: 10.1097/HJH.0b013e3280f9df85. J Hypertens. 2007. PMID: 17563543

2

Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension.

Klein IHHT, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. Klein IHHT, et al. Among authors: ligtenberg g. J Am Soc Nephrol. 2001 Nov;12(11):2427-2433. doi: 10.1681/ASN.V12112427. J Am Soc Nephrol. 2001. PMID: 11675419

3

Pathogenesis and treatment of hypertension in polycystic kidney disease.

Neumann J, Ligtenberg G, Klein IH, Blankestijn PJ. Neumann J, et al. Among authors: ligtenberg g. Curr Opin Nephrol Hypertens. 2002 Sep;11(5):517-21. doi: 10.1097/00041552-200209000-00007. Curr Opin Nephrol Hypertens. 2002. PMID: 12187316 Review.

4

Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure.

Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. Klein IH, et al. Among authors: ligtenberg g. J Am Soc Nephrol. 2003 Feb;14(2):425-30. doi: 10.1097/01.asn.0000045049.72965.b7. J Am Soc Nephrol. 2003. PMID: 12538743 Clinical Trial.

5

Sympathetic nerve activity is inappropriately increased in chronic renal disease.

Klein IH, Ligtenberg G, Neumann J, Oey PL, Koomans HA, Blankestijn PJ. Klein IH, et al. Among authors: ligtenberg g. J Am Soc Nephrol. 2003 Dec;14(12):3239-44. doi: 10.1097/01.asn.0000098687.01005.a5. J Am Soc Nephrol. 2003. PMID: 14638922

6

Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment.

Neumann J, Ligtenberg G, Klein II, Koomans HA, Blankestijn PJ. Neumann J, et al. Among authors: ligtenberg g. Kidney Int. 2004 May;65(5):1568-76. doi: 10.1111/j.1523-1755.2004.00552.x. Kidney Int. 2004. PMID: 15086894 Free article. Review.

7

Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure.

Neumann J, Ligtenberg G, Oey L, Koomans HA, Blankestijn PJ. Neumann J, et al. Among authors: ligtenberg g. J Am Soc Nephrol. 2004 Nov;15(11):2902-7. doi: 10.1097/01.ASN.0000143471.10750.8C. J Am Soc Nephrol. 2004. PMID: 15504943 Clinical Trial.

8

Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment.

Neumann J, Ligtenberg G, Klein IH, Boer P, Oey PL, Koomans HA, Blankestijn PJ. Neumann J, et al. Among authors: ligtenberg g. Hypertension. 2007 Mar;49(3):506-10. doi: 10.1161/01.HYP.0000256530.39695.a3. Epub 2007 Jan 15. Hypertension. 2007. PMID: 17224471

9

Differential effects of acute and sustained cyclosporine and tacrolimus on sympathetic nerve activity.

Klein IH, Abrahams AC, van Ede T, Oey PL, Ligtenberg G, Blankestijn PJ. Klein IH, et al. Among authors: ligtenberg g. J Hypertens. 2010 Sep;28(9):1928-34. doi: 10.1097/HJH.0b013e32833c20eb. J Hypertens. 2010. PMID: 20577127

10

Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus.

Ligtenberg G, Hené RJ, Blankestijn PJ, Koomans HA. Ligtenberg G, et al. J Am Soc Nephrol. 2001 Feb;12(2):368-373. doi: 10.1681/ASN.V122368. J Am Soc Nephrol. 2001. PMID: 11158228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters